Supplemental material
Acta Oncologica
Volume 61, 2022 - Issue 8
Open access
2,418
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology
2-weekly versus 3-weekly docetaxel for metastatic castration-resistant prostate cancer: complete quality of life results from the randomised, phase-III PROSTY trial
Miikka Lehtonena Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;b Katriina Hospital, Vantaa, FinlandCorrespondence[email protected]
https://orcid.org/0000-0001-8249-7767View further author information
Jorma Sormunena Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;c Docrates Cancer Center, Helsinki, FinlandView further author information
, Tiina Luukkaalad Research, Development and Innovation Center, Tampere University Hospital and Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, FinlandView further author information
, Timo Marttilae Seinäjoki Central Hospital, Seinäjoki, FinlandView further author information
, Ray McDermottf St Vincent’s University Hospital and Cancer Trials, Dublin, IrelandView further author information
, Timo Joensuuc Docrates Cancer Center, Helsinki, FinlandView further author information
, Ilari Lehtineng Faculty of Information Technology and Communication Sciences, Tampere University, Tampere, FinlandView further author information
, Claes Ginmanh Karlstad Central Hospital, Karlstad, SwedenView further author information
& Pirkko-Liisa Kellokumpu-Lehtinena Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;i Tampere University Hospital Cancer Center, Tampere, FinlandView further author information
show all
Pages 963-971
|
Received 16 Apr 2022, Accepted 01 Jul 2022, Published online: 18 Jul 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.